189 related articles for article (PubMed ID: 37211001)
21. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
Aden D; Zaheer S; Kumar R; Ranga S
J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
[TBL] [Abstract][Full Text] [Related]
22. Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.
Roper RL; Garzino-Demo A; Del Rio C; Bréchot C; Gallo R; Hall W; Esparza J; Reitz M; Schinazi RF; Parrington M; Tartaglia J; Koopmans M; Osorio J; Nitsche A; Huan TB; LeDuc J; Gessain A; Weaver S; Mahalingam S; Abimiku A; Vahlne A; Segales J; Wang L; Isaacs SN; Osterhaus A; Scheuermann RH; McFadden G
Vaccine; 2023 May; 41(20):3171-3177. PubMed ID: 37088603
[TBL] [Abstract][Full Text] [Related]
23. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R
Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209
[TBL] [Abstract][Full Text] [Related]
24. Mpox diagnostics: Review of current and emerging technologies.
Lim CK; Roberts J; Moso M; Liew KC; Taouk ML; Williams E; Tran T; Steinig E; Caly L; Williamson DA
J Med Virol; 2023 Jan; 95(1):e28429. PubMed ID: 36571266
[TBL] [Abstract][Full Text] [Related]
25. Viral Loads in Skin Samples of Patients with Monkeypox Virus Infection: A Systematic Review and Meta-Analysis.
Rani I; Satapathy P; Goyal A; Shamim MA; Pal A; Squitti R; Goswami K; Pradhan KB; Rustagi S; Hermis AH; Barboza JJ; Rodriguez-Morales AJ; Sah R; Padhi BK
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376686
[TBL] [Abstract][Full Text] [Related]
26. Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreak.
Piorkowski G; Ghosn J; Coppée R; Mailhé M; Ferré VM; Houhou-Fidouh N; Yazdanpanah Y; Le Hingrat Q; Raoul H; Charpentier C; Descamps D; de Lamballerie X
J Med Virol; 2023 Jun; 95(6):e28853. PubMed ID: 37288615
[TBL] [Abstract][Full Text] [Related]
27. AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus.
Patel CN; Mall R; Bensmail H
J Infect Public Health; 2023 May; 16(5):799-807. PubMed ID: 36966703
[TBL] [Abstract][Full Text] [Related]
28. Circulation, viral diversity and genomic rearrangement in mpox virus in the Netherlands during the 2022 outbreak and beyond.
Schuele L; Boter M; Nieuwenhuijse DF; Götz H; Fanoy E; de Vries H; Vieyra B; Bavalia R; Hoornenborg E; Molenkamp R; Jonges M; van den Ouden A; Simões M; van den Lubben M; Koopmans M; Welkers MRA; Oude Munnink BB
J Med Virol; 2024 Jan; 96(1):e29397. PubMed ID: 38235923
[TBL] [Abstract][Full Text] [Related]
29. In silico identification of potential phytochemical inhibitors for mpox virus: molecular docking, MD simulation, and ADMET studies.
Ghate SD; Pinto L; Alva S; Srinivasa MG; Vangala RK; Naik P; Revanasiddappa BC; Rao RSP
Mol Divers; 2024 Mar; ():. PubMed ID: 38519803
[TBL] [Abstract][Full Text] [Related]
30. Human mpox: Biology, epidemiology, therapeutic options, and development of small molecule inhibitors.
Tang H; Zhang A
Med Res Rev; 2023 Jul; 43(4):1019-1037. PubMed ID: 36891882
[TBL] [Abstract][Full Text] [Related]
31. Mpox Virus: Its Molecular Evolution and Potential Impact on Viral Epidemiology.
Yu X; Shi H; Cheng G
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112975
[TBL] [Abstract][Full Text] [Related]
32. Network-based approach for drug repurposing against mpox.
Tang K; Sun Q; Zeng J; Tang J; Cheng P; Qiu Z; Long H; Chen Y; Zhang C; Wei J; Qiu X; Jiang G; Fang Q; Sun L; Sun C; Du X
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132468. PubMed ID: 38761900
[TBL] [Abstract][Full Text] [Related]
33. Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective.
Abduljalil JM; Elfiky AA
J Infect; 2022 Dec; 85(6):702-769. PubMed ID: 36089103
[No Abstract] [Full Text] [Related]
34. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022.
Contag CA; Renfro ZT; Lu J; Shen S; Karan A; Solis D; Huang C; Sahoo MK; Yamamoto F; Jones MS; Lin J; Levy V; Pinsky BA
J Clin Virol; 2023 Jul; 164():105493. PubMed ID: 37220710
[TBL] [Abstract][Full Text] [Related]
36. Gender trend of monkeypox virus infection.
Orassay A; Diassova A; Berdigaliyev A; Liu D; Makhmutova Z; Amin A; Xie Y
Expert Rev Anti Infect Ther; 2023 Jun; 21(6):571-576. PubMed ID: 37039003
[TBL] [Abstract][Full Text] [Related]
37. Mpox virus Clade IIb detection in the air.
Saied AA
J Med Virol; 2023 May; 95(5):e28775. PubMed ID: 37212310
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-Cas12a assisted specific detection of mpox virus.
Singh M; Misra CS; Bindal G; Rangu SS; Rath D
J Med Virol; 2023 Aug; 95(8):e28974. PubMed ID: 37515526
[TBL] [Abstract][Full Text] [Related]
39. Systematic In-Silico Evaluation of the Diagnostic Impact of Mpox Genome Variants in the Current Outbreak.
Vatsyayan A; Arvinden VR; Scaria V
Mol Diagn Ther; 2023 Mar; 27(2):275-280. PubMed ID: 36495397
[TBL] [Abstract][Full Text] [Related]
40. Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico.
Abduljalil JM; Elfiky AA; Elgohary AM
J Infect Public Health; 2023 Jul; 16(7):996-1003. PubMed ID: 37167647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
